[9] Richie JP Jr, Nichenametla S, Neidig W, Calcagnotto A, Haley JS, Schell TD, Muscat JE
Alpha-MSH analogue for pigmentation research
A cohort study revealed an increased risk of pancreatitis, and 36% of patients who used GLP-1 RAs or DPP- 4 inhibitors had elevated serum amylase or lipase (or both) levels compared with 18% of patients not taking these agents ( Our studies showed GLP-1 RA-associated gastrointestinal toxicities occurred 30 days (3,234, 77.44%) after the initiation of GLP-1RAs, and the median time-to-onset was 1 (IQR 024) days with a significant difference between different GLP-1 RA regimens
Each journey is unique what matters is that the results are real and sustainable
It is important to note that Wegovy will remain available for eligible Medicare beneficiaries for other FDA-approved indications through their normal Part D benefits, including to reduce the risk of major adverse cardiovascular events in adults with established CV disease with either obesity or overweight
And it isn't fermentable by oral bacteria, meaning it doesn't produce the acids that lead to cavities
